Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H S Shaw

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Expert Review of Anticancer Therapy|October 18, 2011
Where now for anti-EGF receptor therapies in colorectal cancer?Paul H S Shaw, Richard A Adams
British Journal of Cancer|August 4, 2011
Dual inhibition of epidermal growth factor and insulin-like 1 growth factor receptors reduce intestinal adenoma burden in the Apc(min/+) mouseP H S Shaw, T S Maughan, A R Clarke
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 20, 2007
A clinical review of the investigation and management of carcinoma of unknown primary in a single cancer networkP H S Shaw, R Adams, C Jordan, et al.
Acta Cytologica|December 1, 1999
Effects of chemotherapy and tamoxifen on cervical and vaginal smears in bone marrow transplant recipientsK Liu, J Marshall, H S Shaw, et al.
Molecular Cancer Therapeutics|July 25, 2015
Assessment of the In Vivo Activity of PI3K and MEK Inhibitors in Genetically Defined Models of Colorectal CancerMeera Raja, Matt Zverev, Katja Seipel, et al.
British Journal of Cancer|November 8, 2025
Experimental Cancer Medicine Centre (ECMC) network proposal for a consensus gene panel for pan-cancer sequencing: a Delphi methodologyRichard Phillips, Bristi Basu, Zohra Butt, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Expert Review of Anticancer Therapy|October 18, 2011
Where now for anti-EGF receptor therapies in colorectal cancer?Paul H S Shaw, Richard A Adams
British Journal of Cancer|August 4, 2011
Dual inhibition of epidermal growth factor and insulin-like 1 growth factor receptors reduce intestinal adenoma burden in the Apc(min/+) mouseP H S Shaw, T S Maughan, A R Clarke
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 20, 2007
A clinical review of the investigation and management of carcinoma of unknown primary in a single cancer networkP H S Shaw, R Adams, C Jordan, et al.
Acta Cytologica|December 1, 1999
Effects of chemotherapy and tamoxifen on cervical and vaginal smears in bone marrow transplant recipientsK Liu, J Marshall, H S Shaw, et al.
Molecular Cancer Therapeutics|July 25, 2015
Assessment of the In Vivo Activity of PI3K and MEK Inhibitors in Genetically Defined Models of Colorectal CancerMeera Raja, Matt Zverev, Katja Seipel, et al.
British Journal of Cancer|November 8, 2025
Experimental Cancer Medicine Centre (ECMC) network proposal for a consensus gene panel for pan-cancer sequencing: a Delphi methodologyRichard Phillips, Bristi Basu, Zohra Butt, et al.
Pageof 1